Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP)

4.18
Delayed Data
As of Apr 28
 +0.07 / +1.70%
Today’s Change
3.30
Today|||52-Week Range
37.70
-11.08%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization57.0K56.0K50.0K43.0K
 
 
 
 
 
 
Operating ExpensesGross Income-57.0K-56.0K-50.0K-43.0K
 
 
 
 
 
General Expenses14.0M9.8M7.6M7.5M
 
 
 
 
 
Research And Development10.7M7.5M5.5M4.9M
 
 
 
 
 
Total Operating Expenses14.0M9.8M7.6M7.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-14.0M-9.8M-7.6M-7.5M
 
 
 
 
 
Extraordinary Credit24.0K22.0K16.0K11.0K
 
 
 
 
 
Other Expenses14.0K8.0K15.0K17.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-14.0M-9.8M-7.6M-7.5M
 
 
 
 
 
Net Income-14.0M-9.8M-7.6M-7.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.9M2.0M2.6M391.8K
 
 
 
 
 
Shares To Calculate EPS Diluted1.9M2.0M2.6M391.8K
 
 
 
 
 
 
Earnings Per ShareEPS-$7.40-$5.00-$2.90--
 
 
 
 
EPS Diluted-$7.40-$5.00-$2.90-$19.10